204 related articles for article (PubMed ID: 16012011)
21. [Urinary tract infections in Dakar: etiologies, therapeutic basis].
Sow AI; Diop N; Ndour CT; Soumare M; Seydi M; Cisse MF; Samb A
Dakar Med; 2000; 45(1):59-61. PubMed ID: 14666793
[TBL] [Abstract][Full Text] [Related]
22. [Raoultella ornithinolytica in urinary tract infections. Clinical and microbiological study of a series of 4 oncologic patients].
García-Lozano T; Pascual Plá FJ; Aznar Oroval E
Med Clin (Barc); 2013 Aug; 141(3):138-9. PubMed ID: 23332629
[No Abstract] [Full Text] [Related]
23. [Urinary infections by enterobacteriaceae resistent to antimicrobial agents].
Ales Reinlein JM; Vela Navarrete R; Fernández Puentes MC; Silva M
Rev Clin Esp; 1973 Aug; 130(4):295-300. PubMed ID: 4755593
[No Abstract] [Full Text] [Related]
24. [Sensitivity profiles of enterobacteria isolated at th Fann University Hospital Center, Dakar].
Sow AI; Faye-Niang MA; Mboup EM; Boye CS; Cisse MF; Ndour CT; Soumare M; Seydi M; Gaye M
Dakar Med; 1997; 42(2):123-6. PubMed ID: 9827134
[TBL] [Abstract][Full Text] [Related]
25. Importation of Fosfomycin Resistance fosA3 Gene to Europe.
Mendes AC; Rodrigues C; Pires J; Amorim J; Ramos MH; Novais Â; Peixe L
Emerg Infect Dis; 2016 Feb; 22(2):346-8. PubMed ID: 26812028
[No Abstract] [Full Text] [Related]
26. In vitro resistance of a 4-quinolone after two years of clinical use.
Drlicek M; Grisold W; Armbruster C; Vetter N
J Chemother; 1989 Jul; 1(4 Suppl):378-9. PubMed ID: 16312448
[No Abstract] [Full Text] [Related]
27. Resistance in gram-negative bacteria: enterobacteriaceae.
Paterson DL
Am J Med; 2006 Jun; 119(6 Suppl 1):S20-8; discussion S62-70. PubMed ID: 16735147
[TBL] [Abstract][Full Text] [Related]
28. Antimicrobial resistance in outpatient Escherichia coli urinary isolates in Dakar, Senegal.
Sire JM; Nabeth P; Perrier-Gros-Claude JD; Bahsoun I; Siby T; Macondo EA; Gaye-Diallo A; Guyomard S; Seck A; Breurec S; Garin B
J Infect Dev Ctries; 2007 Dec; 1(3):263-8. PubMed ID: 19734603
[TBL] [Abstract][Full Text] [Related]
29. Antimicrobial susceptibility of clinical Escherichia coli isolates from uncomplicated cystitis in women over a 1-year period in Spain.
Gobernado M; Valdés L; Alós JI; García-Rey C; Dal-Ré R; García-de-Lomas J;
Rev Esp Quimioter; 2007 Mar; 20(1):68-76. PubMed ID: 17530038
[TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetic and pharmacodynamic aspects of antimicrobial agents for the treatment of uncomplicated urinary tract infections.
Mazzei T; Cassetta MI; Fallani S; Arrigucci S; Novelli A
Int J Antimicrob Agents; 2006 Aug; 28 Suppl 1():S35-41. PubMed ID: 16829051
[TBL] [Abstract][Full Text] [Related]
31. In vitro activity of fosfomycin against ciprofloxacin-resistant or extended-spectrum beta-lactamase-producing Escherichia coli isolated from urine and blood.
Ko KS; Suh JY; Peck KR; Lee MY; Oh WS; Kwon KT; Jung DS; Lee NY; Song JH
Diagn Microbiol Infect Dis; 2007 May; 58(1):111-5. PubMed ID: 17300900
[TBL] [Abstract][Full Text] [Related]
32. High rates of antimicrobial co-resistance among Enterobacteriaceae: comparative analysis between clinical isolates resistant and susceptible to third-generation cephalosporins.
Goyanes MJ; Cercenado E; Insa R; Morente A; Alcalá L; Bouza E
Rev Esp Quimioter; 2007 Jun; 20(2):216-21. PubMed ID: 17893759
[TBL] [Abstract][Full Text] [Related]
33. [Uncomplicated urinary tract infections, what about fosfomycin and nitrofurantoin in 2006?].
Honderlick P; Cahen P; Gravisse J; Vignon D
Pathol Biol (Paris); 2006; 54(8-9):462-6. PubMed ID: 17027182
[TBL] [Abstract][Full Text] [Related]
34. Fosfomycin: evaluation of the published evidence on the emergence of antimicrobial resistance in Gram-negative pathogens.
Karageorgopoulos DE; Wang R; Yu XH; Falagas ME
J Antimicrob Chemother; 2012 Feb; 67(2):255-68. PubMed ID: 22096042
[TBL] [Abstract][Full Text] [Related]
35. [Monitoring of resistance to chemotherapeutics of enterobacteria strains isolated from urocultures from out-patients].
Nicodemus T; Văduva DB; Adămuţ M; Linţa M; Velimirovici D; Orb CE; Păun M; Moldovan R
Bacteriol Virusol Parazitol Epidemiol; 2005; 50(1-2):49-57. PubMed ID: 17300031
[TBL] [Abstract][Full Text] [Related]
36. Quinolone antimicrobial resistance in some enterobacteria: a 10-year study in a Venezuelan general hospital.
Rodriguez CN; Rodriguez-Morales AJ; Garcia A; Pastran B; Meijomil P; Barbella RA; Blanco JJ; Vargas JA; Gutierrez G
Int J Antimicrob Agents; 2005 Jun; 25(6):546-50. PubMed ID: 15893917
[No Abstract] [Full Text] [Related]
37. Antimicrobial resistance among enterobacteriaceae causing uncomplicated urinary tract infections in Mauritius: consequences of past misuse of antibiotics.
Issack MI; Yee Kin Tet HY; Morlat P
J Chemother; 2007 Apr; 19(2):222-5. PubMed ID: 17434833
[TBL] [Abstract][Full Text] [Related]
38. Clinical evaluation of guidelines and therapeutic approaches in multi drug-resistant urinary tract infections.
Concia E; Bragantini D; Mazzaferri F
J Chemother; 2017 Dec; 29(sup1):19-28. PubMed ID: 29271735
[TBL] [Abstract][Full Text] [Related]
39. Outcomes of Fosfomycin Use in Ceftriaxone-Resistant Enterobacteriaceae Urinary Tract Infection in the Elderly.
Quek WM; Teng CB; Tan YZ; Chong K; Lye DC; Ng TM
Int J Antimicrob Agents; 2019 Feb; 53(2):195-196. PubMed ID: 30722963
[No Abstract] [Full Text] [Related]
40. CTX-M-15-producing urinary Escherichia coli O25b-ST131-phylogroup B2 has acquired resistance to fosfomycin.
Oteo J; Orden B; Bautista V; Cuevas O; Arroyo M; Martínez-Ruiz R; Pérez-Vázquez M; Alcaraz M; García-Cobos S; Campos J
J Antimicrob Chemother; 2009 Oct; 64(4):712-7. PubMed ID: 19671590
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
